Dorman Products (NASDAQ: DORM) reported Q1 EPS of $1.31, $0.46 better than the analyst estimate of $0.85. Revenue for the quarter came in at $468.7 million versus the consensus estimate of $483.86 million.

GUIDANCE:

Dorman Products sees FY2024 EPS of $5.40-$5.70, versus the consensus of $5.55.
2024 Guidance
The Company confirms its 2024 full-year guidance and expects net sales growth in the range of 3% to 5% over 2023, diluted EPS in the range of $4.71 to $5.01. This guidance assumes a tax rate of 24%, includes the impact of a previously announced reduction in workforce, and excludes any potential impacts from future acquisitions and divestitures, supply chain disruptions, significant inflation and interest rate changes, and share repurchases.

For earnings history and earnings-related data on Dorman Products (DORM) click here.